184 related articles for article (PubMed ID: 14708709)
1. Challenges in therapy of chronic hepatitis B.
Hoofnagle JH
J Hepatol; 2003; 39 Suppl 1():S230-5. PubMed ID: 14708709
[No Abstract] [Full Text] [Related]
2. Chronic HBV without e antigen: using HBV DNA to guide management.
Tran T; Martin P
Am J Gastroenterol; 2003 Oct; 98(10):2115-7. PubMed ID: 14572554
[No Abstract] [Full Text] [Related]
3. [Factors predicting the disappearance of virus B replication markers following treatment with lamivudine].
Buffet C
Presse Med; 2003 Jan; 32(2):53-4. PubMed ID: 12653025
[No Abstract] [Full Text] [Related]
4. High dose lamivudine and hepatitis B.
Musher DR; Wasser WG; Saggi SJ
Am J Gastroenterol; 1999 Nov; 94(11):3372. PubMed ID: 10566751
[No Abstract] [Full Text] [Related]
5. Is ribavirin treatment really effective for chronic hepatitis B?
Kakumu S
J Gastroenterol; 2000; 35(5):404-6. PubMed ID: 10832679
[No Abstract] [Full Text] [Related]
6. [Interferon therapy for chronic hepatitis B].
Kakumu S
Nihon Rinsho; 2004 Aug; 62 Suppl 8():315-20. PubMed ID: 15453337
[No Abstract] [Full Text] [Related]
7. KASL clinical practice guidelines for management of chronic hepatitis B.
Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol; 2019 Jun; 25(2):93-159. PubMed ID: 31185710
[No Abstract] [Full Text] [Related]
8. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.
Chan HL; Tang JL; Tam W; Sung JJ
Aliment Pharmacol Ther; 2001 Dec; 15(12):1899-905. PubMed ID: 11736720
[TBL] [Abstract][Full Text] [Related]
9. [Management of HBeAg negative chronic hepatitis B].
Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):539. PubMed ID: 16042896
[No Abstract] [Full Text] [Related]
10. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus - recent therapeutic advances and challenges to cure.
Mouzannar K; Liang TJ
J Hepatol; 2020 Sep; 73(3):694-695. PubMed ID: 32682539
[No Abstract] [Full Text] [Related]
12. Chronic hepatitis B in children and adolescents.
Paganelli M; Stephenne X; Sokal EM
J Hepatol; 2012 Oct; 57(4):885-96. PubMed ID: 22634122
[No Abstract] [Full Text] [Related]
13. [Combination therapy of lamivudine and HB vaccine for the treatment of chronic hepatitis B].
Ishikawa T; Kakumu S
Nihon Rinsho; 2004 Aug; 62 Suppl 8():331-5. PubMed ID: 15453340
[No Abstract] [Full Text] [Related]
14. [Are phyllanthus species effective in hepatitis B?].
Rakowitz B
Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1460. PubMed ID: 21732258
[No Abstract] [Full Text] [Related]
15. [Chronic hepatitis B, advances in treatment].
Buffet C
Presse Med; 2006 Feb; 35(2 Pt 2):302-3. PubMed ID: 16493333
[No Abstract] [Full Text] [Related]
16. Changing landscape of antiviral resistance management in chronic hepatitis B.
Nguyen T; Locarnini S; Desmond P
J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
[No Abstract] [Full Text] [Related]
17. [Lamivudine treatment for hepatitis B].
Lamivudine Clincal Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
[No Abstract] [Full Text] [Related]
18. [HBeAg-negative chronic hepatitis].
Ibragimova MM; Krel' PE; Abdurakhmanov DT
Ter Arkh; 2004; 76(2):87-91. PubMed ID: 15106425
[No Abstract] [Full Text] [Related]
19. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
Wang FS; Zhang JY
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
[No Abstract] [Full Text] [Related]
20. Hepatitis B virus: healthy carrier or chronic infection?
Prasad AV
Indian J Gastroenterol; 2000; 19(4):198-9. PubMed ID: 11059199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
